δ-Opioid receptors stimulate GLUT1-mediated glucose uptake through Src- and IGF-1 receptor-dependent activation of PI3-kinase signalling in CHO cells

作者: Maria C Olianas , Simona Dedoni , Pierluigi Onali

DOI: 10.1111/J.1476-5381.2011.01234.X

关键词: Protein kinase BInternal medicineGLUT3Glucose homeostasisGlucose uptakeGlucose transporterReceptor tyrosine kinaseProto-oncogene tyrosine-protein kinase SrcEndocrinologyReceptorBiology

摘要: BACKGROUND AND PURPOSE Although opioids have been reported to affect glucose homeostasis, relatively little is known on the role of δ-opioid receptors. We investigated regulation transport by human receptors expressed in Chinese hamster ovary cells. EXPERIMENTAL APPROACH The uptake [3H]-2-deoxy-D-glucose and 3-O-[methyl-[3H]]-D-glucose response receptor ligands expression GLUT1, GLUT3 GLUT4 transporters were examined. Moreover, effects intracellular signal transduction inhibitors receptor-regulated protein phosphorylation investigated. KEY RESULTS Activation rapidly stimulated uptakes, which blocked GLUT cytochalasin B phloretin. stimulation that occurred without a change plasma membrane GLUT1 – required coupling Gi/Go proteins was independent cAMP extracellular signal-regulated kinases, suppressed blockade Src insulin-like growth factor-1 (IGF-1R) tyrosine kinases. Inhibition phosphatidylinositol 3-kinase (PI3K) wortmannin or LY294002 PI3Kα, but not γ, isoform-selective greatly reduced uptake. attenuated overexpressing dominant-negative kinase-deficient Akt form chemical inhibition Akt. Stimulation increased kinase Cζ/λ (PKCζ/λ) selective PKCζ/λ inhibitor slightly opioid uptake. CONCLUSIONS IMPLICATIONS δ-Opioid probably enhancing intrinsic activity through signalling cascade involving Gi/Go, Src, IGF-1R, and, minor extent, PKCζ/λ. This effect may contribute homeostasis physio-pathological conditions.

参考文章(61)
Derek LeRoith, Marcelina Párrizas, Aviv Gazit, Alexander Levitzki, Efrat Wertheimer, Specific Inhibition of Insulin-Like Growth Factor-1 and Insulin Receptor Tyrosine Kinase Activity and Biological Function by Tyrphostins Endocrinology. ,vol. 138, pp. 1427- 1433 ,(1997) , 10.1210/ENDO.138.4.5092
F.-H. Lu, C. J. Chang, J.-T. Cheng, I-M. Liu, T.-C. Chi, T.-F. Tzeng, Plasma glucose-lowering effect of tramadol in streptozotocin-induced diabetic rats. Diabetes. ,vol. 50, pp. 2815- 2821 ,(2001) , 10.2337/DIABETES.50.12.2815
Anne W. Harmon, David S. Paul, Yashomati M. Patel, MEK inhibitors impair insulin-stimulated glucose uptake in 3T3-L1 adipocytes American Journal of Physiology-endocrinology and Metabolism. ,vol. 287, ,(2004) , 10.1152/AJPENDO.00581.2003
Karina Förster, Atsushi Kuno, Natalia Solenkova, Stephan B. Felix, Thomas Krieg, The δ-opioid receptor agonist DADLE at reperfusion protects the heart through activation of pro-survival kinases via EGF receptor transactivation American Journal of Physiology-heart and Circulatory Physiology. ,vol. 293, ,(2007) , 10.1152/AJPHEART.00418.2007
Raymond M. Quock, Cheryl A. Slate, Thomas H. Burkey, Keiko Hosohata, Frederick J. Ehlert, Eva Varga, Henry I. Yamamura, Scott M. Cowell, William R. Roeske, Yoshiaki Hosohata, The δ-Opioid Receptor: Molecular Pharmacology, Signal Transduction, and the Determination of Drug Efficacy Pharmacological Reviews. ,vol. 51, pp. 503- 532 ,(1999)
L. G. Fryer, E. Hajduch, F. Rencurel, I. P. Salt, H. S. Hundal, D. G. Hardie, D. Carling, Activation of glucose transport by AMP-activated protein kinase via stimulation of nitric oxide synthase. Diabetes. ,vol. 49, pp. 1978- 1985 ,(2000) , 10.2337/DIABETES.49.12.1978
Jeffrey C. Rathmell, Casey J. Fox, David R. Plas, Peter S. Hammerman, Ryan M. Cinalli, Craig B. Thompson, Akt-Directed Glucose Metabolism Can Prevent Bax Conformation Change and Promote Growth Factor-Independent Survival Molecular and Cellular Biology. ,vol. 23, pp. 7315- 7328 ,(2003) , 10.1128/MCB.23.20.7315-7328.2003
K. Hara, K. Yonezawa, H. Sakaue, A. Ando, K. Kotani, T. Kitamura, Y. Kitamura, H. Ueda, L. Stephens, T. R. Jackson, 1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 91, pp. 7415- 7419 ,(1994) , 10.1073/PNAS.91.16.7415
R. Brooks Robey, Jianfei Ma, Anna V. P. Santos, Regulation of mesangial cell hexokinase activity by PKC and the classic MAPK pathway. American Journal of Physiology-renal Physiology. ,vol. 277, ,(1999) , 10.1152/AJPRENAL.1999.277.5.F742